FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

7636211000001108: Noradrenaline tartrate 4mg/2ml solution for injection ampoules (Abbott Laboratories Ltd) 6 ampoule (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
29546301000001116 Noradrenaline tartrate 4mg/2ml solution for injection ampoules (Abbott Laboratories Ltd) 6 ampoule (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
106086101000001113 Noradrenaline (base) 2mg/2ml solution for infusion ampoules (Pfizer Ltd) 6 ampoule en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Noradrenaline tartrate 4mg/2ml solution for injection ampoules (Abbott Laboratories Ltd) 6 ampoule Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Noradrenaline tartrate 4mg/2ml solution for injection ampoules (Abbott Laboratories Ltd) 6 ampoule Is a Noradrenaline 4mg/2ml solution for injection ampoules 6 ampoule true Inferred relationship Existential restriction modifier
Noradrenaline tartrate 4mg/2ml solution for injection ampoules (Abbott Laboratories Ltd) 6 ampoule Is pack of Noradrenaline tartrate 4mg/2ml solution for injection ampoules (Abbott Laboratories Ltd) false Inferred relationship Existential restriction modifier
Noradrenaline tartrate 4mg/2ml solution for injection ampoules (Abbott Laboratories Ltd) 6 ampoule Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Noradrenaline tartrate 4mg/2ml solution for injection ampoules (Abbott Laboratories Ltd) 6 ampoule Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Noradrenaline tartrate 4mg/2ml solution for injection ampoules (Abbott Laboratories Ltd) 6 ampoule Has active ingredient Norepinephrine false Inferred relationship Existential restriction modifier
Noradrenaline tartrate 4mg/2ml solution for injection ampoules (Abbott Laboratories Ltd) 6 ampoule Has active ingredient Norepinephrine bitartrate false Inferred relationship Existential restriction modifier
Noradrenaline tartrate 4mg/2ml solution for injection ampoules (Abbott Laboratories Ltd) 6 ampoule Has excipient Sodium metabisulfite false Inferred relationship Existential restriction modifier
Noradrenaline tartrate 4mg/2ml solution for injection ampoules (Abbott Laboratories Ltd) 6 ampoule Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Noradrenaline tartrate 4mg/2ml solution for injection ampoules (Abbott Laboratories Ltd) 6 ampoule Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Noradrenaline tartrate 4mg/2ml solution for injection ampoules (Abbott Laboratories Ltd) 6 ampoule VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Noradrenaline tartrate 4mg/2ml solution for injection ampoules (Abbott Laboratories Ltd) 6 ampoule VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Noradrenaline tartrate 4mg/2ml solution for injection ampoules (Abbott Laboratories Ltd) 6 ampoule Has manufactured dose form Conventional release solution for injection false Inferred relationship Existential restriction modifier
Noradrenaline tartrate 4mg/2ml solution for injection ampoules (Abbott Laboratories Ltd) 6 ampoule Has AMP Noradrenaline tartrate 4mg/2ml solution for injection ampoules (Abbott Laboratories Ltd) true Inferred relationship Existential restriction modifier
Noradrenaline tartrate 4mg/2ml solution for injection ampoules (Abbott Laboratories Ltd) 6 ampoule Has specific active ingredient Norepinephrine bitartrate true Inferred relationship Existential restriction modifier
Noradrenaline tartrate 4mg/2ml solution for injection ampoules (Abbott Laboratories Ltd) 6 ampoule Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Noradrenaline tartrate 4mg/2ml solution for injection ampoules (Abbott Laboratories Ltd) 6 ampoule Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Noradrenaline tartrate 4mg/2ml solution for injection ampoules (Abbott Laboratories Ltd) 6 ampoule Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Norepinephrine true Inferred relationship Existential restriction modifier
Noradrenaline tartrate 4mg/2ml solution for injection ampoules (Abbott Laboratories Ltd) 6 ampoule Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Noradrenaline tartrate 4mg/2ml solution for injection ampoules (Abbott Laboratories Ltd) 6 ampoule Has basis of strength substance Norepinephrine true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start